SGRY - Surgery Partners Inc Stock Price, Fair Value and News

$21.22+1.61 (+8.21%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

SGRY Price Action

Last 7 days

4.2%

Last 30 days

-5.7%

Last 90 days

-34.8%

Trailing 12 Months

-35.9%

SGRY RSI Chart

SGRY Valuation

Market Cap

2.7B

Price/Earnings (Trailing)

-44.51

Price/Sales (Trailing)

0.9

Price/Free Cashflow

16.51

SGRY Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

SGRY Fundamentals

SGRY Revenue

Revenue (TTM)

3.0B

Rev. Growth (Yr)

14.29%

Rev. Growth (Qtr)

1.09%

SGRY Earnings

Earnings (TTM)

-60.6M

Earnings Growth (Yr)

-546.94%

Earnings Growth (Qtr)

-104.52%

SGRY Profitability

Operating Margin

52.85%

Return on Equity

-3.2%

Return on Assets

-0.8%

Free Cashflow Yield

6.06%

SGRY Investor Care

Shares Dilution (1Y)

0.49%

Diluted EPS (TTM)

-0.47

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.8B	2.9B	3.0B	0
2023	2.6B	2.7B	2.7B	2.7B
2022	2.3B	2.4B	2.4B	2.5B
2021	1.9B	2.1B	2.2B	2.2B
2020	1.9B	1.8B	1.8B	1.9B
2019	1.8B	1.8B	1.8B	1.8B
2018	1.5B	1.7B	1.9B	1.8B
2017	1.2B	1.2B	1.1B	1.4B
2016	1.0B	1.1B	1.1B	1.1B
2015	557.0M	713.0M	876.3M	959.9M
2014	314.3M	343.9M	373.6M	403.3M
2013	0	0	0	284.6M

Get all data in R, Python etc through our Historical Stock Data APIs

About Surgery Partners Inc

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. The company was founded in 2004 and is headquartered in Brentwood, Tennessee.

CEO	Mr. J. Eric Evans
WEBSITE	surgerypartners.com
SECTOR	Healthcare
INDUSTRY	Medical Care Facilities
EMPLOYEES	9100

Surgery Partners Inc Frequently Asked Questions

What is the ticker symbol for Surgery Partners Inc? What does SGRY stand for in stocks?

SGRY is the stock ticker symbol of Surgery Partners Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Surgery Partners Inc (SGRY)?

As of Fri Dec 20 2024, market cap of Surgery Partners Inc is 2.7 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SGRY stock?

You can check SGRY's fair value in chart for subscribers.

Is Surgery Partners Inc a good stock to buy?

The fair value guage provides a quick view whether SGRY is over valued or under valued. Whether Surgery Partners Inc is cheap or expensive depends on the assumptions which impact Surgery Partners Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SGRY.

What is Surgery Partners Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, SGRY's PE ratio (Price to Earnings) is -44.51 and Price to Sales (PS) ratio is 0.9. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SGRY PE ratio will change depending on the future growth rate expectations of investors.